Name: Latest research reports of Supriya Lifescience Ltd. authored by KRChoksey and published by - Trendlyne research reports.
Item: Supriya Lifescience Ltd.
Rating: 4
Author: KRChoksey

Supriya Lifescience Ltd.

NSE: SUPRIYA | BSE: 543434 | ISIN: INE07RO01027 | Industry: Pharmaceuticals
| Expensive Performer

727.6000 -16.20 (-2.18%)

NSE Apr 22, 2025 15:31 PM

120.48% Gain from 52W Low

Volume: 262.6K

Supriya Lifescience Ltd.

18 Aug 2022

727.60

-2.18%

Improving capabilities towards sustainable growth.

Accumulate: Supriya Lifescience Ltd.

KRChoksey

During Q1FY23, Supriya Lifescience Ltd (SLL) reported Revenue of INR 1,037 Mn (+31.43% YoY / -43.98% QoQ).

Number of FII/FPI investors increased from 85 to 98 in Mar 2025 qtr.